PD-1 antibody (Internal Region)
-
- Target See all PD-1 (PDCD1) Antibodies
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
-
Binding Specificity
- Internal Region
-
Reactivity
- Human
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- This PD-1 antibody is un-conjugated
-
Application
- Flow Cytometry (FACS), ELISA
- Purpose
- PDCD1
- Sequence
- GELDFQWREK TPE
- Predicted Reactivity
- Human, Mouse, Rat, Dog, Cow
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Grade
- Verified
- Immunogen
- Peptide with sequence C-GELDFQWREKTPE, from the internal region of the protein sequence according to NP_005009.2.
- Isotype
- IgG
- Top Product
- Discover our top product PDCD1 Primary Antibody
-
-
- Application Notes
-
Peptide ELISA: antibody detection limit dilution 1:128000.
- Comment
-
Flow Cytometry: Flow cytometric analysis of Jurkat cells. Recommended concentration: 10ug/ml.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- PD-1 (PDCD1) (Programmed Cell Death 1 (PDCD1))
- Alternative Name
- PDCD1 (PDCD1 Products)
- Synonyms
- CD279 antibody, PD-1 antibody, PD1 antibody, SLEB2 antibody, hPD-1 antibody, hPD-l antibody, Ly101 antibody, Pdc1 antibody, programmed cell death 1 antibody, PDCD1 antibody, Pdcd1 antibody
- Background
- PDCD1, programmed cell death 1, HGNC:8760, PD1, SLEB2, hPD-1, hPD-l, programmed death 1, CD279
- Gene ID
- 5133
- NCBI Accession
- NP_005009
- Pathways
- Cancer Immune Checkpoints
-